SIGNIFICANCE OF METABOLIC AND BLOOD-PRESSURE FACTORS IN RELATION TO MICROANGIOPATHY AND MACROANGIOPATHY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
S. Okada et al., SIGNIFICANCE OF METABOLIC AND BLOOD-PRESSURE FACTORS IN RELATION TO MICROANGIOPATHY AND MACROANGIOPATHY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of international medical research, 24(1), 1996, pp. 99-108
Citations number
28
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
We are actively seeking methods to prevent and to limit the progressio
n of angiopathy in patients with non-insulin-dependent diabetes mellit
us (NIDDM). In the present study, we conducted a clinical and epidemio
logical survey to clarify the clinical factors responsible for the dev
elopment and progression of diabetic microangiopathy (MI) and macroang
iopathy (MA). A total of 107 patients (58 female and 49 male) were ran
domly selected from 145 NIDDM patients. Twenty-four patient variables
were selected for analysis. We identified PWV, UAI, RETINOP, MCV-T, SC
V-S, MCV-P, SEP, and DBP as responsible factors and carried out stepwi
se multiple regression analyses. The following explanatory variables w
ere found to be significant: age > SCV-S (P < 0.0001) for the criterio
n variable PWV, BUN > HbA(1C) > MCV-P > HT-drug > HDL-C (P < 0.0001) f
or log(e) UAI, DM-thera > SBP (P < 0.0001) for RETINOP, MCV-P (P < 0.0
001) for MCV-T, IRI > SEP > MCV-P > S-CR (P < 0.0002) for SCV-S, MCV-T
> SCV-S > DM-thera (P < 0.0001) for MCV-P, DBP > HT-drug > BUN > MCV-
P (P < 0.0001) for SBP, and SBP > PWV > sex (P < 0.0001) for DBP, In s
ummary, responsible factors for MI and MA in NIDDM had metabolic and b
lood pressure factors in common, Moreover, MI was a responsible factor
for MA, which becomes a responsible factor for MI because it is a res
ponsible factor for blood pressure factors, Thus, all the responsible
factors for MA represented by MI and PWV had metabolic and blood press
ure factors in common, The results of this study suggest that metaboli
c and blood pressure factors must be controlled to prevent and to limi
t the progression of diabetic MI and MA in NIDDM patients.